TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)

CUSIP: 881624209

Q3 2021 13F Holders as of 30 Sep 2021

Security type / class
Equity / Ordinary Shares, par value NIS 0.01 per share
Total 13F shares
527,166,334
Total 13F value
$5,134,182,484
Holder snapshot 6 visible 7 signals
Share change
-32,508,205
Put/Call ratio
110%
SEC-reported price per share
$9.74
Number of holders
408
Value change
-$316,368,771
Number of buys
151
Open additional details 1 more signal available
Number of sells
172
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,148,777,709

Security key

881624209

Report period

Q3 2021

Institutions

408

Top holders

10

TEVA full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2021 Previous quarter: Q2 2021 TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings TEVA PHARMACEUTICAL INDUSTRIES LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.
Comparable ownership Top 5
Capital Research Global Investors 11%
Capital World Investors 4.3%
BERKSHIRE HATHAWAY INC 3.7%
BlackRock Finance, Inc. 3.5%
ABRAMS CAPITAL MANAGEMENT, L.P. 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital Research Global Investors
13F
Company
13F
11%
$1,214,277,000
122,652,574 shares
 — 30 Jun 2021
Capital World Investors
13F
Company
13F
4.3%
$488,436,000
49,336,350 shares
 — 30 Jun 2021
BERKSHIRE HATHAWAY INC
13F
Company
13F
3.7%
$423,615,000
42,789,295 shares
 — 30 Jun 2021
BlackRock Finance, Inc.
13F
Company
13F
3.5%
$393,587,000
39,756,043 shares
 — 30 Jun 2021
ABRAMS CAPITAL MANAGEMENT, L.P.
13F
Company
13F
2.1%
$238,059,000
24,046,356 shares
 — 30 Jun 2021
Migdal Insurance & Financial Holdings Ltd.
13F
Company
13F
1.7%
$196,141,000
19,790,036 shares
 — 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
408
Shares
527,166,334
Rows available
408
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
423
Q3 2021 holders
408
Holder diff
-15
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .